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Introduction 
The New Delhi Metallo ß-lactamase gene (blaNDM-1) is an emerging plasmid-borne resistance 
mechanism that codes for an Ambler class B, zinc dependent, ß-lactamase enzyme that 
confers resistance to penicillins, cephalosporins and carbapenems.  Organisms harbouring the 
blaNDM-1 gene invariably carry resistance to other antimicrobials including fluoroquinolones, 
sulphonamides and aminoglycosides. Some isolates have been described as ‘pan-resistant’.  
We present in-depth analysis of a blaNDM-1 E. coli isolate causing community -acquired 
cystitis in a traveller to India.  
 
Methods 
Antimicrobial resistance was determined by disc and E-test sensitivity testing. Molecular 
analysis included investigation of resistance mechanisms by gene amplification and 
sequencing. Plasmid transformation experiments were used to understand the transferability 
of plasmids harbouring identified antimicrobial resistance genes. 
 
Results 
Phenotypic analysis demonstrated resistance to all antimicrobials assayed with the exception 
of colistin, tigecycline, nitrofurantoin and chloramphenicol. Molecular analysis demonstrated 
the presence of the blaNDM-1 gene, the ESBL gene blaCTX-M-15, the AmpC gene blaCMY and the 
emerging aminoglycoside resistance genes rmtC and aac(6’)Ib.  
 
Discussion 
Analysis of this blaNDM-1 harboring E. coli, highlights the emerging complexity of 
antimicrobial resistance genetics and epidemiology. The isolate carries many antimicrobial 
resistance genes including three broad-spectrum ß-lactamases. These reside on multiple 
mobile plasmids that could potentially transfer to other organisms. This infection was 
acquired during travel - without health system contact - to a country within our region and 
presented to a suburban local doctor in Australia. Such importation of community acquired 
blaNDM-1 infection has not been previously described in Australia and raises the possibility of 
community transmission locally.  	  
